SC revokes remisier's licence over improper practices


Datuk Kamarudin Meranun has entered into a settlement with the Securities Commission for RM3.64mil over the purchase of 5.55 million Malaysia Airlines Bhd (MAS) shares between Aug 1, 2011 and Aug 5, 2011.

KUALA LUMPUR: The Securities Commission (SC) has revoked the Capital Markets Services Representative’s Licence (CMSRL) of Chu Li Choon for various improper business practices when transacting for her client.

The regulator said on Thursday the revocation was effective May 10.

“Chu’s CMSRL was revoked under Section 72 read together with section 65 of the Capital Markets and Services Act 2007 (CMSA), as she is no longer fit and proper to carry out regulated activities in the Malaysian capital market. Chu was formerly attached with CIMB Investment Bank,” it said.

The SC also imposed a penalty of RM100,000 against Chu for failing to comply with the condition of her CMSRL which requires her to remain fit and proper at all times as provided under Paragraph 7.03(1) of the SC’s Licensing Handbook. 

“The SC has considered and rejected an appeal by Chu against the SC’s decision,” it said. 

The Star Christmas Special Promo: Save 35% OFF Yearly. T&C applies.

Monthly Plan

RM 13.90/month

Best Value

Annual Plan

RM 12.33/month

RM 8.02/month

Billed as RM 96.20 for the 1st year, RM 148 thereafter.

Follow us on our official WhatsApp channel for breaking news alerts and key updates!
Chu Li Choon , remisier , Capital Markets

Next In Business News

UK economy slowed to show 0.1% growth in third quarter, ONS says
Bank Negara international reserves edge up to US$124.3bil as at Dec 15
Evergreen Max Cash secures four new pawnbroking licences from KPKT
Asia shares extend gains, yen friendless as bonds buckle
Trump shook up global trade this year; some uncertainty may persist in 2026
Yinson unit enters 15-year PPA with Genesis Energy of New Zealand
Malaysian durians sell out fast in Hainan after customs shift
Betamek wins six-year Perodua contract worth RM176mil
SSBB launches mandatory offer for Nova Pharma after RM18.19mil stake buy
Crest Builder secures RM73.9mil mixed-use project subcontract

Others Also Read